Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Case Studies: Myeloproliferative Neoplasms
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
The Clinical Management of Primary Myelofibrosis
Diagnosis and Treatment of Myelofibrosis
Managing Uncontrolled Polycythemia Vera
A Case of Hydroxyurea Intolerant Polycythemia Vera
High-Risk Primary Myelofibrosis
Hydroxyurea Resistant Polycythemia Vera
Underlying Treatment of Myeloproliferative Neoplasms
Uncontrolled Polycythemia Vera
Harry Erba, MD, PhD, provides information on the diagnosis and treatment of patients with polycythemia vera
Srdan Verstovsek, MD, provides information on the diagnosis and treatment of patients with polycythemia vera
JTT Articles
Presence of MSI-H, MMR-D Predicts Lynch Syndrome Across Tumor Types
RET Rearrangements in Non-Small Cell Lung Cancer
Integrating Mutational Analysis Into the Clinical Management of Patients With Myelofibrosis
>> View Peer-Reviewed Articles
Most Popular
Despite Previous Findings, Prostate Cancer Analysis Shows Risk of Death Lower in African-Americans
Kuzel Discusses Treatment Options for Metastatic RCC Based on Risk Stratification
Case 1: Prognostic Features and Chemoimmunotherapy Treatment Options
Case 1: Targeted Therapy: Ibrutinib for Newly Diagnosed CLL
Publications
